The foundation of Phoreus's offerings is its Peptide Nanoparticles (PNPs) platform. These are self-assembling nanostructures engineered to encapsulate a diverse range of therapeutic molecules, including small molecules, proteins, and nucleic acids, for improved transport and delivery within the body.

• ·Capable of encapsulating small molecules, proteins, nucleic acids, and peptides.
• ·Features a modular design that allows for targeted delivery, reducing off-target effects and toxicity.
• ·Demonstrates minimized immune responses compared to lipid-based carriers.
• ·Supports alternative administration routes such as buccal, transdermal, and pulmonary delivery.